Novel mutations conferring resistance to kanamycin in Mycobacterium tuberculosis clinical isolates from Northern India

被引：10

作者：

Kaur, Simerpreet ^{[1
]}

Rana, Vibhuti ^{[1
]}

Singh, Pooja ^{[2
]}

Trivedi, Garima ^{[1
]}

Anand, Shashi ^{[1
]}

Kaur, Amanpreet ^{[1
]}

Gupta, Pawan ^{[1
]}

Jain, Amita ^{[2
]}

Sharma, Charu ^{[1
]}

机构：

[1] CSIR Inst Microbial Technol, Sect 39A, Chandigarh 160036, India

[2] King George Med Univ, Dept Microbiol, Lucknow 226003, Uttar Pradesh, India

来源：

TUBERCULOSIS | 2016年 / 96卷

关键词：

Molecular characterization; Aminoglycosides; MDR-TB; XDR-TB; RESAZURIN MICROTITER ASSAY; MOLECULAR CHARACTERIZATION; DRUG-RESISTANCE; TRANSCRIPTIONAL ACTIVATOR; CAPREOMYCIN RESISTANCE; ANTIBIOTIC-RESISTANCE; CROSS-RESISTANCE; AMIKACIN; REGION; WHIB7;

D O I：

10.1016/j.tube.2015.10.012

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Twenty-nine Kanamycin resistant clinical isolates of Mycobacterium tuberculosis from Northern India were screened to evaluate genetic mutations in rrs gene, eis gene with its promoter, and whiB7 gene along with its 5'UTR. 14 strains (-48.0%) collectively exhibited mutations in rrs, eis or whiB7 target regions. While the highest frequency of mutations was found in rrs gene, eis and whiB7 loci displayed novel mutations. The novel mutations displayed by eis and whiB7 loci were found to be associated specifically with the Kanamycin resistance as none of the twenty nine Kanamycin sensitive strains harbor them. The inclusion of novel mutations of eis and whiB7 loci will be useful in improving the specificity of future diagnostics. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：96 / 101

页数：6

共 30 条

[1] Mutation Detection and Accurate Diagnosis of Extensively Drug-Resistant Tuberculosis: Report from a Tertiary Care Center in India
Ajbani, Kanchan
Rodrigues, Camilla
Shenai, Shubhada
Mehta, Ajita
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (04) : 1588 - 1590
[2] Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis
Alangaden, GJ
Kreiswirth, BN
Aouad, A
Khetarpal, M
Igno, FR
Moghazeh, SL
Manavathu, EK
Lerner, SA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) : 1295 - 1297
[3] Aslan G, 2008, JPN J INFECT DIS, V61, P255
[4] Extensively drug-resistant tuberculosis in California, 1993-2006
Banerjee, Ritu
Allen, Jennifer
Westenhouse, Janice
Oh, Peter
Elms, William
Desmond, Ed
Nitta, Annette
Royce, Sarah
Flood, Jennifer
[J]. CLINICAL INFECTIOUS DISEASES, 2008, 47 (04) : 450 - 457
[5] The mycobacterial antibiotic resistance determinant WhiB7 acts as a transcriptional activator by binding the primary sigma factor SigA (RpoV)
Burian, Jan
Yim, Grace
Hsing, Michael
Axerio-Cilies, Peter
Cherkasov, Artem
Spiegelman, George B.
Thompson, Charles J.
[J]. NUCLEIC ACIDS RESEARCH, 2013, 41 (22) : 10062 - 10076
[6] Burian J, 2012, EXPERT REV ANTI-INFE, V10, P1037, DOI [10.1586/eri.12.90, 10.1586/ERI.12.90]
[7] Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosis
Campbell, Patricia J.
Morlock, Glenn P.
Sikes, R. David
Dalton, Tracy L.
Metchock, Beverly
Starks, Angela M.
Hooks, Delaina P.
Cowan, Lauren S.
Plikaytis, Bonnie B.
Posey, James E.
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (05) : 2032 - 2041
[8] Genotypic Susceptibility Testing of Mycobacterium tuberculosis Isolates for Amikacin and Kanamycin Resistance by Use of a Rapid Sloppy Molecular Beacon-Based Assay Identifies More Cases of Low-Level Drug Resistance than Phenotypic Lowenstein-Jensen Testing
Chakravorty, Soumitesh
Lee, Jong Seok
Cho, Eun Jin
Roh, Sandy S.
Smith, Laura E.
Lee, Jiim
Kim, Cheon Tae
Via, Laura E.
Cho, Sang-Nae
Barry, Clifton E., III
Alland, David
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2015, 53 (01) : 43 - 51
[9] World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
Di Angelantonio, Emanuele
Kaptoge, Stephen
Pennells, Lisa
De Bacquer, Dirk
Cooney, Marie Therese
Kavousi, Maryam
Stevens, Gretchen
Riley, Leanne
Savin, Stefan
Altay, Servet
Amouyel, Philippe
Assmann, Gerd
Bell, Steven
Ben-Shlomo, Yoav
Berkman, Lisa
Beulens, Joline W.
Bjorkelund, Cecilia
Blaha, Michael J.
Blazer, Dan G.
Bolton, Thomas
Bonita, Ruth
Brenner, Beaglehole Hermann
Brunner, Eric J.
Casiglia, Edoardo
Chamnan, Parinya
Choi, Yeun-Hyang
Chowdhury, Rajiv
Coady, Sean
Crespo, Carlos J.
Cushman, Mary
Dagenais, Gilles R.
D'Agostino, Ralph B.
Daimon, Makoto
Davidson, Karina W.
Engstrom, Gunnar
Fang, Xianghua
Ford, Ian
Gallacher, John
Gansevoort, Ron T.
Gaziano, Thomas Andrew
Giampaoli, Simona
Grandits, Greg
Grimsgaard, Sameline
Grobbee, Diederick E.
Gudnason, Vilmundur
Guo, Qi
Humphries, Steve
Iso, Hiroyasu
Jukema, J. Wouter
Kauhanen, Jussi
[J]. LANCET GLOBAL HEALTH, 2019, 7 (10): : E1332 - E1345
[10] Evaluation of nitrate reduction assay, resazurin microtiter assay and microscopic observation drug susceptibility assay for first line antitubercular drug susceptibility testing of clinical isolates of M. tuberculosis
Dixit, Pratima
Singh, Urmila
Sharma, Pratibha
Jain, Amita
[J]. JOURNAL OF MICROBIOLOGICAL METHODS, 2012, 88 (01) : 122 - 126

← 1 2 3 →